Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice

被引:387
作者
Iafrati, MD
Karas, RH
Aronovitz, M
Kim, S
Sullivan, TR
Lubahn, DB
ODonnell, TF
Korach, KS
Mendelsohn, ME
机构
[1] TUFTS UNIV NEW ENGLAND MED CTR,MOL CARDIOL RES CTR,TUPPER RES INST,BOSTON,MA 02111
[2] UNIV MISSOURI,DEPT BIOCHEM,COLUMBIA,MO 65201
[3] UNIV MISSOURI,DEPT CHILD HLTH,COLUMBIA,MO 65201
[4] NIEHS,REPROD & DEV TOXICOL LAB,NIH,RES TRIANGLE PK,NC 27709
关键词
D O I
10.1038/nm0597-545
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The atheroprotective effects of estrogen in women are well recognized(1), but the underlying mechanisms responsible are not well understood. Blood vessel cells express the classic estrogen receptor, ER alpha (ref. 2-6), and are directly affected by estrogen, which inhibits the development of atherosclerotic and injury-induced vascular lesions(7,8). We have generated mice in which the ER alpha gene is disrupted(9) and have used a mouse model of carotid arterial injury to compare the effects of estrogen on wild-type and estrogen receptor-deficient mice. Increases in vascular medial area and smooth muscle cell proliferation were quantified following vascular injury in ovariectomized mice treated with vehicle or with physiologic levels of 17 beta-estradiol. Suprisingly, in both wild-type and estrogen receptor-deficient mice, 17 beta-estradiol markedly inhibited to the same degree all measures of vascular injury. These data demonstrate that estrogen inhibits vascular injury by a novel mechanism that is independent of the classic estrogen receptor, ER alpha.
引用
收藏
页码:545 / 548
页数:4
相关论文
共 44 条
[1]   INHIBITION OF CORONARY-ARTERY ATHEROSCLEROSIS BY 17-BETA ESTRADIOL IN OVARIECTOMIZED MONKEYS - LACK OF AN EFFECT OF ADDED PROGESTERONE [J].
ADAMS, MR ;
KAPLAN, JR ;
MANUCK, SB ;
KORITNIK, DR ;
PARKS, JS ;
WOLFE, MS ;
CLARKSON, TB .
ARTERIOSCLEROSIS, 1990, 10 (06) :1051-1057
[2]   Ethinylestradiol does not enhance the expression of nitric oxide synthase in bovine endothelial cells but increases the release of bioactive nitric oxide by inhibiting superoxide anion production [J].
Arnal, JF ;
Clamens, S ;
Pechet, C ;
NegreSalvayre, A ;
Allera, C ;
Girolami, JP ;
Salvayre, R ;
Bayard, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (09) :4108-4113
[3]   ESTROGEN ACTION VIA THE CAMP SIGNALING PATHWAY - STIMULATION OF ADENYLATE-CYCLASE AND CAMP-REGULATED GENE-TRANSCRIPTION [J].
ARONICA, SM ;
KRAUS, WL ;
KATZENELLENBOGEN, BS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (18) :8517-8521
[4]   Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice [J].
Bourassa, PAK ;
Milos, PM ;
Gaynor, BJ ;
Breslow, JL ;
Aiello, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (19) :10022-10027
[5]   The CREB family of transcription activators [J].
Brindle, Paul K. ;
Montminy, Marc R. .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1992, 2 (02) :199-204
[6]   Effects of 17 beta-estradiol on cytokine-induced endothelial cell adhesion molecule expression [J].
CaulinGlaser, T ;
Watson, CA ;
Pardi, R ;
Bender, JR .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :36-42
[7]  
CHANG WC, 1980, BIOCHIM BIOPHYS ACTA, V620, P472
[8]   Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery [J].
Chen, SJ ;
Li, HB ;
Durand, J ;
Oparil, S ;
Chen, YF .
CIRCULATION, 1996, 93 (03) :577-584
[9]   ESTROGEN-BINDING SITES IN ENDOTHELIAL CELL-CULTURES [J].
COLBURN, P ;
BUONASSISI, V .
SCIENCE, 1978, 201 (4358) :817-819
[10]   ANALYSIS OF TRANSCRIPTION AND ESTROGEN INSENSITIVITY IN THE FEMALE MOUSE AFTER TARGETED DISRUPTION OF THE ESTROGEN-RECEPTOR GENE [J].
COUSE, JF ;
CURTIS, SW ;
WASHBURN, TF ;
LINDZEY, J ;
GOLDING, TS ;
LUBAHN, DB ;
SMITHIES, O ;
KORACH, KS .
MOLECULAR ENDOCRINOLOGY, 1995, 9 (11) :1441-1454